These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12190870)

  • 1. Latent and active transforming growth factor beta1 released from genetically modified keratinocytes modulates extracellular matrix expression by dermal fibroblasts in a coculture system.
    Bauer BS; Tredget EE; Marcoux Y; Scott PG; Ghahary A
    J Invest Dermatol; 2002 Aug; 119(2):456-63. PubMed ID: 12190870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
    Ghahary A; Tredget EE; Shen Q
    J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically modified dermal keratinocytes express high levels of transforming growth factor-beta1.
    Ghahary A; Tredget EE; Chang LJ; Scott PG; Shen Q
    J Invest Dermatol; 1998 May; 110(5):800-5. PubMed ID: 9579549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, characterization, and wound healing of the keratin 14 promoted transforming growth factor-beta1 transgenic mouse.
    Chan T; Ghahary A; Demare J; Yang L; Iwashina T; Scott PG; Tredget EE
    Wound Repair Regen; 2002; 10(3):177-87. PubMed ID: 12100379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannose-6-phosphate/IGF-II receptors mediate the effects of IGF-1-induced latent transforming growth factor beta 1 on expression of type I collagen and collagenase in dermal fibroblasts.
    Ghahary A; Tredget EE; Shen Q; Kilani RT; Scott PG; Houle Y
    Growth Factors; 2000; 17(3):167-76. PubMed ID: 10705575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts.
    Ghahary A; Karimi-Busheri F; Marcoux Y; Li Y; Tredget EE; Taghi Kilani R; Li L; Zheng J; Karami A; Keller BO; Weinfeld M
    J Invest Dermatol; 2004 May; 122(5):1188-97. PubMed ID: 15140222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocyte conditioned medium abrogates the modulatory effects of IGF-1 and TGF-beta1 on collagenase expression in dermal fibroblasts.
    Kilani RT; Guilbert L; Lin X; Ghahary A
    Wound Repair Regen; 2007; 15(2):236-44. PubMed ID: 17352756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal fibroblasts from different layers of human skin are heterogeneous in expression of collagenase and types I and III procollagen mRNA.
    Ali-Bahar M; Bauer B; Tredget EE; Ghahary A
    Wound Repair Regen; 2004; 12(2):175-82. PubMed ID: 15086769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells.
    Xia W; Phan TT; Lim IJ; Longaker MT; Yang GP
    Wound Repair Regen; 2004; 12(5):546-56. PubMed ID: 15453837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratinocytes suppress transforming growth factor-beta1 expression by fibroblasts in cultured skin substitutes.
    Le Poole IC; Boyce ST
    Br J Dermatol; 1999 Mar; 140(3):409-16. PubMed ID: 10233258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oxidized regenerated cellulose on the expression of extracellular matrix and transforming growth factor-beta1 in human peritoneal fibroblasts and mesothelial cells.
    Gago LA; Saed GM; Wang RX; Kruger M; Diamond MP
    Am J Obstet Gynecol; 2003 Dec; 189(6):1620-5; discussion 1625-6. PubMed ID: 14710085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions.
    Lan CC; Fang AH; Wu PH; Wu CS
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):204-15. PubMed ID: 23301526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts.
    Ylä-Outinen H; Aaltonen V; Björkstrand AS; Hirvonen O; Lakkakorpi J; Vähä-Kreula M; Laato M; Peltonen J
    J Invest Dermatol; 1998 Mar; 110(3):232-7. PubMed ID: 9506441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of transforming growth factor-beta1, fibronectin, and Types I, III, and VI collagen genes in fascial fibroblasts from patients with diffuse fasciitis with eosinophilia.
    Kahari L; Jimenez SA
    J Rheumatol; 1996 Mar; 23(3):482-6. PubMed ID: 8832987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin.
    Ghaffari A; Li Y; Karami A; Ghaffari M; Tredget EE; Ghahary A
    J Cell Biochem; 2006 May; 98(2):383-93. PubMed ID: 16440305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of transforming growth factor beta 1 by insulin-like growth factor-1 in dermal fibroblasts.
    Ghahary A; Shen Q; Shen YJ; Scott PG; Tredget EE
    J Cell Physiol; 1998 Mar; 174(3):301-9. PubMed ID: 9462692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts.
    Daian T; Ohtsuru A; Rogounovitch T; Ishihara H; Hirano A; Akiyama-Uchida Y; Saenko V; Fujii T; Yamashita S
    J Invest Dermatol; 2003 Jun; 120(6):956-62. PubMed ID: 12787120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte differentiation inversely regulates the expression of involucrin and transforming growth factor beta1.
    Ghahary A; Marcoux Y; Karimi-Busheri F; Tredget EE
    J Cell Biochem; 2001 Aug 1-9; 83(2):239-48. PubMed ID: 11573241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoskeleton regulates expression of genes for transforming growth factor-beta 1 and extracellular matrix proteins in dermal fibroblasts.
    Varedi M; Ghahary A; Scott PG; Tredget EE
    J Cell Physiol; 1997 Aug; 172(2):192-9. PubMed ID: 9258340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.